Drugs / Dendritic Cell Tumor Fusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00458653 | Apr 2005 → Apr 2012 | plasma cell myeloma | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic Cell Tumor Fusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00458653 ↗ |
| Route | Subcutaneous | “Given under the skin every four weeks for three doses.” NCT00458653 ↗ |